Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.
about
Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status.Mucinous Cystadenocarcinoma of the Breast with Estrogen Receptor Expression: A Case Report and Review of the LiteratureExperimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitorsC²Maps: a network pharmacology database with comprehensive disease-gene-drug connectivity relationships.Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signalingTamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cellsTamoxifen non-estrogen receptor mediated molecular targets.Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonismEvaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifeneAutophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells.ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention.Statins and risk of breast cancer recurrence.Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvementSuccessful management of multi-focal hepatic infantile hemangioendothelioma using TACE/surgery followed by maintenance metronomic therapy.
P2860
Q31097623-BC1526FF-45A8-41A9-8F59-D0D533437D3EQ34038053-B42726C1-3FDB-4998-80F0-3658C226AB15Q34082909-1D1E81D1-A9D3-417E-93D6-82B975438D21Q34470187-6085CF58-947E-4368-A72F-CC700CC548C3Q34700117-8D8BADA9-E5C7-4C39-B978-AAFB8F42783AQ34753820-D77127DB-9A0E-4501-8BD3-00AF576E27A5Q35000235-AB4D29CB-93D0-4FFD-A00B-8C310818CA27Q35569331-94866EA9-8FBA-4CD4-982E-D5AD66C0A529Q35748908-1FE54456-3BA2-4FDE-8E76-FD24D3346B46Q35933230-B1A8CF66-CBA2-49B3-BAFF-010270DA668FQ36739017-D2526F8E-67AA-490E-AD7F-2AA6C4E676D8Q37280527-394AE807-40AE-4A98-BD59-C79CAF7C9147Q37407449-94290DF0-CF20-4BEC-A5D6-760EEA2553D2Q38842969-8342DFCA-80F8-465B-94E6-84F428AB7CE3Q42560952-6F658271-3B47-48CD-9637-426321BA42BA
P2860
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.
@ast
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.
@en
type
label
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.
@ast
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.
@en
prefLabel
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.
@ast
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.
@en
P2093
P1476
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models
@en
P2093
Blackwell KL
Broadwater G
Dewhirst MW
Greenberg CS
P304
P407
P577
2000-11-01T00:00:00Z